fbpx
News
January 23, 2014

In the News Today – January 23, 2014

“Fighting fraud is a great idea,” editorializes the Charleston Daily Mail. But a proposed state bill modeled after the federal False Claims Act won’t improve the accountability of the government. Rather, it will encourage frivolous litigation and enrich plaintiffs’ lawyers, the Daily Mail writes.

A group of 28 Republican legislators sent a letter to the FDA asking the agency to reconsider a proposal that would allow generic drugmakers to change a label without the agency’s approval. In September, ILR president Lisa Rickard wrote the rule change is “a prescription for mega lawsuits.” CQ

Shareholder lawsuits against Johnson & Johnson have been dismissed after the lawyer fees were resolved, reports Main Justice. Some investors objected to the $10 million fee request for the suits stemming from the company’s FCPA settlements, questioning whether the lawyers deserved the payout.

FCA lawsuits healthcare costs Blog An Easy Way to Reduce Health Care Costs: Fix FCA Lawsuits False Claims Act (FCA) Supreme Court Qui Tam Action Blog Supreme Court to Review Qui Tam Action Dismissal Standards  False Claims Act (FCA) Podcasts Episode 18: Why Federal Securities Suits Don’t Belong in State Court Securities Litigation Reform Blog Law 360 Expert Analysis: "False Claims Act Proposal Is Unfair And Would Hinder Economic Growth" False Claims Act (FCA) Stock data News D&O Diary Looks At 2021 Litigation Trends Securities Litigation Reform

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Review Settings